{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T15:01:14Z","timestamp":1784991674639,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Kobe City Medical Center General Hospital"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.lungcan.2015.09.002","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T15:03:23Z","timestamp":1441724603000},"page":"364-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Transformation to large cell neuroendocrine carcinoma as acquired resistance mechanism of EGFR tyrosine kinase inhibitor"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9696-8371","authenticated-orcid":false,"given":"Mariko","family":"Kogo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Kokubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Tomii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.lungcan.2015.09.002_bib0005","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.lungcan.2015.09.002_bib0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial","volume":"11","author":"Mitsudomi","year":"2010","journal-title":"Lancet Oncol."},{"issue":"25","key":"10.1016\/j.lungcan.2015.09.002_bib0015","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR","volume":"362","author":"Maemondo","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.lungcan.2015.09.002_bib0020","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1200\/JCO.2011.40.1315","article-title":"Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial","volume":"30","author":"Janne","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2015.09.002_bib0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4046\/trd.2013.75.3.95","article-title":"Neuroendocrine differentiation in acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitor","volume":"75","author":"Chang","year":"2013","journal-title":"Tuberc. Respir. Dis."},{"issue":"8","key":"10.1016\/j.lungcan.2015.09.002_bib0030","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1158\/1078-0432.CCR-12-2246","article-title":"Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers","volume":"19","author":"Yu","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.lungcan.2015.09.002_bib0035","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1440-1843.2012.02258.x","article-title":"Large-cell neuroendocrine carcinoma with epidermal growth factor receptor mutation: possible transformation of lung adenocarcinoma","volume":"17","author":"Yanagisawa","year":"2012","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.lungcan.2015.09.002_bib0040","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3904\/kjim.2014.29.6.830","article-title":"Transformation into large-cell neuroendocrine carcinoma associated with acquired resistance to erlotinib in nonsmall cell lung cancer","volume":"29","author":"Jeong","year":"2014","journal-title":"Korean J. Intern. Med."},{"key":"10.1016\/j.lungcan.2015.09.002_bib0045","series-title":"Who Classification of Tumours of the Lung, Pleura Thymus and Heart","author":"William","year":"2015"},{"issue":"1","key":"10.1016\/j.lungcan.2015.09.002_bib0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2214\/ajr.182.1.1820087","article-title":"CT findings of surgically resected large cell neuroendocrine carcinoma of the lung in 38 patients","volume":"182","author":"Oshiro","year":"2004","journal-title":"Am. J. Roentgenol."},{"issue":"1","key":"10.1016\/j.lungcan.2015.09.002_bib0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1477-7819-11-205","article-title":"Combined large cell neuroendocrine carcinoma with giant cell carcinoma of the lungs: a case report","volume":"11","author":"Hayashi","year":"2013","journal-title":"World J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2015.09.002_bib0060","first-page":"1177","article-title":"Pathologic diagnosis of large cell neuroendocrine carcinoma of the lung in an axillary lymph node: a case report with immunohistochemical and molecular genetic studies","volume":"6","author":"Tadashi","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.lungcan.2015.09.002_bib0065","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.lungcan.2013.04.005","article-title":"Rapid increase of serum neuron specific enolase level and tachyphylaxis ofEGFR-tyrosine kinase inhibitor indicate small cell lung cancer transformationfrom EGFR positive lung adenocarcinoma?","volume":"81","author":"Zhang","year":"2013","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.lungcan.2015.09.002_bib0070","first-page":"556","article-title":"A clinical study of advanced large cell neuroendocrine carcinoma","volume":"44","author":"Kishi","year":"2006","journal-title":"Nihon Kokyuki Gakkai Zasshi. J. Jpn. Respir. Soc."},{"issue":"3","key":"10.1016\/j.lungcan.2015.09.002_bib0075","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.lungcan.2009.07.003","article-title":"Comparison of chemotherapy for unresectable pulmonary high-grade non-small cell neuroendocrine carcinoma and small-cell lung cancer","volume":"68","author":"Igawa","year":"2010","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2015.09.002_bib0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.lungcan.2012.04.009","article-title":"Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer?","volume":"77","author":"Sun","year":"2012","journal-title":"Lung Cancer"},{"issue":"75","key":"10.1016\/j.lungcan.2015.09.002_bib0085","doi-asserted-by":"crossref","first-page":"75ra26","DOI":"10.1126\/scitranslmed.3002003","article-title":"Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors","volume":"3","author":"Sequist","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lungcan.2015.09.002_bib0090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12885-015-1084-5","article-title":"Lung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN","volume":"15","author":"Collaud","year":"2015","journal-title":"BMC Cancer"},{"issue":"41","key":"10.1016\/j.lungcan.2015.09.002_bib0095","doi-asserted-by":"crossref","first-page":"14788","DOI":"10.1073\/pnas.1410419111","article-title":"ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers","volume":"111","author":"Augustyn","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.lungcan.2015.09.002_bib0100","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/cncr.20108","article-title":"Genetic alterations in early-stage pulmonary large cell neuroendocrine carcinoma","volume":"100","author":"Hiroshima","year":"2004","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.lungcan.2015.09.002_bib0105","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/modpathol.3800659","article-title":"Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis","volume":"19","author":"Hiroshima","year":"2006","journal-title":"Mod. Pathol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215300477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215300477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T12:27:41Z","timestamp":1537360061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500215300477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0169500215300477"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.09.002","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transformation to large cell neuroendocrine carcinoma as acquired resistance mechanism of EGFR tyrosine kinase inhibitor","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}